2-t-Butyl-5,5-dimethyltetrahydrofuran | 66728-67-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧唑烯
• 英文名称: 2-t-Butyl-5,5-dimethyltetrahydrofuran
• 英文别名: 5-tert-butyl-2,2-dimethyl-tetrahydro-furan；2,2-Dimethyl-5-t-butyltetrahydrofuran；5-tert-butyl-2,2-dimethyloxolane
• CAS: 66728-67-4
• 化学式: C₁₀H₂₀O
• 分子量: 156.268
• InChiKey: LENHCTFWOSUTAK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
  申请人：AMGEN INC.

  公开号：US20170320860A1

  公开（公告）日：2017-11-09

  Compounds of Formula I and Formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

  公式I和公式II的化合物，其药用盐，上述任何一个的立体异构体，或它们的混合物是APJ受体的激动剂，可能用于治疗心血管和其他疾病。公式I和公式II的化合物具有以下结构： 其中变量的定义在此提供。
• Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
  申请人：Spencer John

  公开号：US20070082892A1

  公开（公告）日：2007-04-12

  This invention relates to a compound of formula (I). The compound is useful for the treatment of gastrin related disorders.

  本发明涉及一种式（I）的化合物。该化合物可用于治疗胃泌素相关疾病。
• BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
  申请人：Bruce Ian

  公开号：US20150025059A1

  公开（公告）日：2015-01-22

  Bicyclic heterocyclic derivatives of formula I useful in inhibiting PDGF receptor mediated biological activity. wherein A is and R 1 , R 1a , R 2 , R 3 , R 4 , R 5 , R 6 and X are as defined herein.

  公式I中的双环杂环衍生物可用于抑制PDGF受体介导的生物活性，其中A为，R1，R1a，R2，R3，R4，R5，R6和X如本文所定义。
• Perfluoropolyether Group-Containing Acrylate Compound
  申请人：Shin-Etsu Chemical Co., Ltd.

  公开号：EP2270071A1

  公开（公告）日：2011-01-05

  The present invention relates to a photo-curable perfluoropolyether group-containing acrylate compound represented by the following formula (1):         X1-[Z-Rf-Z-X2]v-Z-Rf-Z-X1     (1) wherein Rf is a divalent perfluoropolyether group; X1 is a group represented by the following formula (2) : R2 is a group represented by the following formula (4) : X2 is a group represented by the following formula (5): and Z is a divalent organic group.

  本发明涉及一种含全氟聚醚基团的光固化丙烯酸酯化合物，由下式（1）表示： X1-[Z-Rf-Z-X2]v-Z-Rf-Z-X1 (1) 其中 Rf 为二价全氟聚醚基团； X1 是由下式（2）代表的基团： R2 是下式（4）所代表的基团： X2 是下式（5）所代表的基团： Z 是二价有机基团。
• Curable composition, process for producing same, and article produced therewith
  申请人：DAIKIN INDUSTRIES, LTD.

  公开号：US11008466B2

  公开（公告）日：2021-05-18

  A curable composition including a compound having a perfluoropolyether group and a curable moiety, and a curable resin and/or a curable monomer, wherein an organic solvent having no radical reactive group is not substantially contained. The curable composition is capable of forming a surface-treating layer that is in a lower clouded state.

  一种可固化组合物，包括一种具有全氟聚醚基团和可固化分子的化合物，以及一种可固化树脂和/或一种可固化单体，其中基本不含不含自由基活性基团的有机溶剂。该可固化组合物能够形成处于较低浊度状态的表面处理层。